Federal regulators warn that nanotechnology could present dangers to consumers

health insurance news

FDA calls for proof of safety for nanotechnology Nanotechnology is gaining traction in the world of medicine. The technology has a myriad of uses from prosthetics to cancer treatment, but the federal Food and Drug Administration (FDA) believes that nanotechnology could present serious dangers to consumers. Health regulators have released a study concerning nanotechnology and have warned that products that use this technology cold have harmful effects on the human body. The health insurance industry is also wary of the technology because these possible effects could be somewhat costly. Nanoparticles…

Read More

First large insurance company is ceasing coverage of Avastin breast cancer drug

Blue Shield in California, which is a health insurance company with 3.2 million members… is the first among the large insurers in the company to announce that they will no longer be providing coverage for the breast cancer drug called Avastin, following a unanimous recommendation by a federal advisory committee that the Food and Drug Administration rescind the medication’s approval as a treatment for the disease, stating that patients were not helped by its use. That said, Avastin is still holding onto its approval, as commissioner Dr. Margaret A. Hamburg…

Read More